CRO Clinical Research Management was awarded a contract by the Department of Health and Human Services, NIH, Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID). The intent of the award is to provide a broad spectrum of services for the design and conduct of phase I-IV clinical trials and clinical studies focused on the screening, diagnosis, treatment, prevention and control of sexually transmitted infections within the Sexually Transmitted Infections Clinical Trials Group (STI CTG) Program.

ClinicalRM has partnered with Johns Hopkins University (JHU) and is one of only three other companies to be awarded this contract. The total costs of the program will be financed with federal money. The contract ceiling for the seven-year program for all awardees is $70 million.

The mission of the program is to foster, develop and administer a research program that will contribute to human reproductive health, and lead to the prevention and control of STIs. The broad public health goals of this research program focus on the prevention of STIs and associated syndromes; infertility; adverse outcomes of pregnancy, including preterm birth and low birth weight; and reproductive tract neoplasia.